期刊文献+

双色荧光原位杂交技术在膀胱尿路上皮肿瘤诊断中的应用价值 被引量:2

Diagnostic application value of urothelial carcinoma of the urinary bladder by dual color fluorescence in-situ hybridization
原文传递
导出
摘要 目的探讨双色荧光原位杂交技术(FISH)诊断膀胱尿路上皮肿瘤的临床应用价值。方法标记为3、7、17号染色体着丝粒及9号染色体p16位点9p21区带探针,采用FISH对80例膀胱尿路上皮肿瘤患者尿液间期细胞核进行FISH,同时选取20例健康体检者作为正常对照组,建立阈值,以组织病理结果作为诊断“金标准”,统计染色体畸变情况,分析其与病理分期、分级的关系以及染色体畸变组合诊断膀胱尿路上皮肿瘤的敏感性。结果3、7、17号染色体和9p21的畸变率分别为47.5%(38/80)、60.7%(49/80)、51.3%(41/80)和58.8%(47/80),3、7、9和17号染色体联合检测膀胱癌的阳性率为76.3%(61/80),畸变和肿瘤分期无相关性,3、7、17号染色体与肿瘤病理分级有显著相关性(P〈0.05)。结论膀胱尿路上皮肿瘤的进展可能与染色体的畸变有关,FISH可以作为膀胱尿路上皮肿瘤诊断的一项重要方法,并可能在术后监测复发以及预后判断中具有重要临床意义。 Objective To evaluate the clinical application value of dual color fluorescence in-situ hybridization (FISH) in detecting urothelial carcinoma of the urinary bladder. Methods The probes of chromosome 3, 7, 17centromeres and chromosome 9p21 region (p16) were labeled by random primer method. FISH was performed on interphase nuclei of 80 urine specimens of cancer of the urinary bladder and 20 cases of healthy persons served as normal controls. Threshold value was established. The pathological diagnosis was the "golden standard". Chromosome aberration was counted. The correlations between chromosome aberration and pathologic grading and staging and their sensibility of diagnosis for urothelial carcinoma of the urinary bladder were analyzed. Results The rate of numerical aberration of chromosome 3, 7, 17, 9p21 was 47. 5% (38/80) ,60.7% (49/80), 51.3% (41/80) and 58.8% (47/80) respectively. The positive rate of the combined use of 3, 7, 17 and 9p21 chromosome probes for detecting urothelial carcinoma of urinary bladder was 76.3% (61/80). The aberrations had no correlation to tumor stage. The aberration of chromosome 3, 7 and 17 were correlated to pathologic grade significantly ( P 〈 0.05 ). Conclusion The progression of urothelial carcinoma of the urinary bladder is related to the aberrations of chromosome. FISH is believed to be a very important method in diagnosis of urothelial carcinoma of the urinary bladder, which may have important clinical significance for the postoperative recurrence detection and prognosis.
出处 《国际肿瘤学杂志》 CAS 2012年第3期237-240,共4页 Journal of International Oncology
基金 卫生部科研基金课题(WKJ2007-3-001)
关键词 荧光原位杂交技术 尿路上皮肿瘤 染色体畸变 诊断 Fluorescence in situ hybridization Urothelial cancinoma Chromosome aberration Diagnosis
  • 相关文献

参考文献15

  • 1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics , 2002.CA Cancer J Clin, 2005, 55(2) :74-108.
  • 2Schmidbauer J, Witjes F, Schmeller N, et ai. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol, 2004, 171 ( 1 ) : 135-138.
  • 3Kuzniacka A, Mertens F, Strombeck B, et ai. Comnined binary ratio labeling fluorescence in situ hybridization ananlysis of chrome. Cancer Genet Cytogenet, 2004, 151 ( 2 ) : 178-181.
  • 4Hailing KC, King W, Sokolova IA, et ai. A comparison of cytology and fluorescence in situ hybridization for the .detection of bladder cancer. J Urol, 2000, 164(5) :1768-1775.
  • 5Hailing KC, King W, Sokolova IA, et ai. A comparison of BAT stat, hemoglobin for dip stick telomerase and Vysis Urovysion assays for the detection of urotheliai carcinoma in urine. J Urol, 2002, 167 (5) : 2001-2006.
  • 6Lu ML, Wikman F, Orntoft TF, et al. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods. Clin Cancer Res, 2002, 8 (1) :171-179.
  • 7Qin SL, Chen X J, Xu X, et ai. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization. Cancer Lett, 2006, 238 ( 2 ) : 230- 239.
  • 8Kruger S, Mess F, Bohle A, et al. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary blad- der. Int J Oneol, 2003, 23( 1 ) :41-48.
  • 9Sandberg AA, Berger CS. Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J Urol, 1994, 151(3):545-560.
  • 10Shapiro GI, Edwards CD, Kobzik L, et al. Reciprocal Rb inactivation and pl6 expression in primary lung cancers and cell lines. Can cer Res, 1995, 55 (3) :505-509.

二级参考文献19

  • 1全国肿瘤防治研究办公室.卫生部统计信心中心.中国试点县、市恶性肿瘤的发病与死亡[M].北京:中国医药科技出版社,2002:24—34.
  • 2Prout G R Jr, Barton B A, Griffin P P, et al. Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group [J]. J Urol, 1992,148 (5):1413-1419.
  • 3Raitanen M P, Kaasinen E, Lukkarinen O, et al. Analysis of false-positive BTA STAT test results in patients followe dup for bladder cancer [J]. Urology, 2001,57(4) :680-684.
  • 4Inoue T, Nasu Y, Tsushima T, et al. Chromosomal numerical aberrations of exfoliated cells in the urine detected by fluorescence in situ hybridization: clinical implication for the detection of bladder cancer [J]. Urol Res, 2000,28(1):57-61.
  • 5Sokolova I A, Halling K C, Jenkins R B, et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urotheliai carcinoma in urine [J]. J Mol Diagn, 2000,2(3):116-123.
  • 6Halling K C, King W, Sokolova I A, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma [J]. J Urol, 2000,164(5) :1768-1775.
  • 7Zhang J, Zheng S, Gao Y, et al. A partial allelotyping of urothelial carcinoma of bladder in the Chinese [J].Carcinogenesis, 2004,25 (3): 343-347.
  • 8Veeramachaneni R, Nordberg M L, Shi R, et al. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma [J]. Diagn Cytopathol, 2003,28 (6): 301-307.
  • 9Kruger S, Mess F, Bohle A, et al. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder [J]. Int J Oncol, 2003,23 (1): 41-48.
  • 10Mhawech-Fauceglia P, Fischer G, Beck A, et al. Raf1,Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up [J]. Eur J Surg Ongol, 2006,32(4):439-444.

共引文献26

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部